Loss of Medicaid Coverage During the Renewal Process
This study examines national trends in the use of and spending on oral anticoagulants among U.S. Medicare beneficiaries from 2011 to 2019.
The cross-sectional study analyzes patterns in the adoption of direct oral anticoagulants (DOACs) and their impact on Medicare expenditures.
Findings indicate a significant increase in DOAC use over the study period, leading to higher overall spending on anticoagulant therapies within the Medicare program. The study highlights the financial implications of shifting prescribing practices toward newer anticoagulant medications.
Share this Resource:
